Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Deuster

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
HNO|April 27, 2012
[Nonorganic (functional) hearing loss in children]C-M Schmidt, A Am Zehnhoff-Dinnesen, D Deuster
HNO|January 27, 2006
[The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy]C-M Schmidt, E Bartholomäus, D Deuster, et al.
Neuropediatrics|July 4, 2007
Melatonin is a useful alternative to sedation in children undergoing brainstem audiometry with an age dependent success rate--a field report of 250 investigationsC-M Schmidt, A Knief, D Deuster, et al.
Laryngo- Rhino- Otologie|August 19, 2004
[The use of melatonin as an alternative to sedation in children undergoing brainstem audiometry]C-M Schmidt, J E Bohlender, D Deuster, et al.
The Pharmacogenomics Journal|April 26, 2007
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatinL Riedemann, C Lanvers, D Deuster, et al.
HNO|March 10, 2012
[Identifying language and communication disorders as part of the medical curriculum]D Deuster, A am Zehnhoff-Dinnesen, A Knief, et al.
HNO|October 12, 2012
[Pedaudiological diagnostics in the first year of life . Clinical follow-up, risk factors, and middle ear function]J W Rumstadt, A am Zehnhoff-Dinnesen, A Knief, et al.
Pediatric Blood & Cancer|November 23, 2005
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parametersC Lanvers-Kaminsky, B Krefeld, A G Dinnesen, et al.
NPJ Precision Oncology|July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE studyA J M Meijer, F A Diepstraten, T Langer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
HNO|April 27, 2012
[Nonorganic (functional) hearing loss in children]C-M Schmidt, A Am Zehnhoff-Dinnesen, D Deuster
HNO|January 27, 2006
[The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy]C-M Schmidt, E Bartholomäus, D Deuster, et al.
Neuropediatrics|July 4, 2007
Melatonin is a useful alternative to sedation in children undergoing brainstem audiometry with an age dependent success rate--a field report of 250 investigationsC-M Schmidt, A Knief, D Deuster, et al.
Laryngo- Rhino- Otologie|August 19, 2004
[The use of melatonin as an alternative to sedation in children undergoing brainstem audiometry]C-M Schmidt, J E Bohlender, D Deuster, et al.
The Pharmacogenomics Journal|April 26, 2007
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatinL Riedemann, C Lanvers, D Deuster, et al.
HNO|March 10, 2012
[Identifying language and communication disorders as part of the medical curriculum]D Deuster, A am Zehnhoff-Dinnesen, A Knief, et al.
HNO|October 12, 2012
[Pedaudiological diagnostics in the first year of life . Clinical follow-up, risk factors, and middle ear function]J W Rumstadt, A am Zehnhoff-Dinnesen, A Knief, et al.
Pediatric Blood & Cancer|November 23, 2005
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parametersC Lanvers-Kaminsky, B Krefeld, A G Dinnesen, et al.
NPJ Precision Oncology|July 15, 2021
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE studyA J M Meijer, F A Diepstraten, T Langer, et al.
Pageof 1